FNY Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Sell
15
-200
-93% -$17.5K ﹤0.01% 824
2026
Q1
$19K Sell
215
-220
-51% -$20.2K 0.01% 479
2025
Q4
$39K Sell
435
-300
-41% -$28.4K 0.01% 481
2025
Q3
$72K Buy
735
+45
+7% +$4.46K 0.02% 434
2025
Q2
$62K Buy
690
+290
+73% +$28K 0.03% 362
2025
Q1
$45K Buy
400
+190
+90% +$20.3K 0.03% 300
2024
Q4
$22K Sell
210
-10
-5% -$1.07K 0.01% 420
2024
Q3
$23K Buy
+220
New +$24K 0.01% 385
2019
Q2
Sell
-438
Closed -$54K 1168
2019
Q1
$54K Buy
+438
New +$49.8K 0.02% 324

Other funds holding ZBH

FNY Investment Advisers's ZBH Position: Q2 2026 in Review

FNY Investment Advisers reduced its Zimmer Biomet (ZBH) stake by 93% in Q2 2026, selling an estimated $17.5K and leaving 15 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #824.

FNY Investment Advisers first reported a position in ZBH in Q1 2019 and has held it in 9 quarters since. The position peaked at $72K in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • FNY Investment Advisers held 15 shares of Zimmer Biomet worth $1K as of Q2 2026.
  • FNY Investment Advisers sold 200 Zimmer Biomet shares in Q2 2026, an estimated $17.5K.
  • Zimmer Biomet made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #824 holding.
  • FNY Investment Advisers first reported a position in Zimmer Biomet in Q1 2019 and has held it in 9 quarters since.
  • FNY Investment Advisers's Zimmer Biomet position peaked at $72K in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.